{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T15:13:14Z","timestamp":1776265994394,"version":"3.50.1"},"reference-count":32,"publisher":"Centre for Evaluation in Education and Science (CEON\/CEES)","issue":"4","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/BY\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Med Biochemistry"],"published-print":{"date-parts":[[2026]]},"abstract":"<jats:p>Background: To explore the relationships between the levels of serum insulin-like growth factor binding protein-3 (IGFBP-3) and insulin-like growth factor 1 (IGF-1) and immune factors, as well as the prognosis of patients with uterine fibroids. Methods: The study group consisted of 186 patients with uterine fibroids who had laparoscopic myomectomy between June 2023 and June 2024, whereas the control group consisted of 208 healthy women who had physical tests over the same time period. The patients in the study group were divided into a good prognosis group (84 patients) and a poor prognosis group (92 patients). The levels of GFBP-3, IGF-1 and immune factors in the study group and the control group, and their relationships with prognosis were analysed. Results: Ten patients left the study group, and eight left the control group. IGFBP-3 and IGF-1 in the study group were (3 03.18\u00b1 42.39) mg\/L and (1377.11 \u00b1 84.78) mg\/L, which both outperformed those in the control contingent [(231.2 5 \u00b1 3 4 .1 8) mg\/L and (4 3 8 .0 9 \u00b1 5 2 .1 5) mg\/L] (t= 12.87, 19.63) P&amp;lt; 0.001). Whereas the levels of CD3+, CD 4+, and CD 4+\/CD 8+ were lower than those in the control group (t= 7.92, 8.41, 5.21, P&amp;lt; 0.001). Both values were higher [(284.63\u00b1 36.19) mg\/L and (4 34.91\u00b1 53.28) mg\/L]. P&amp;lt;0.001 (t= 5.96, 64.19). While the numbers of CD 3+, CD 4+, and CD 4+\/CD 8+ cells were lower than those in the good prognosis group (t= 5.31, 7.03, 3.15). There was a positive correlation between CD8+ status and IGFBP-3, as well as history of uterine fibroids, number of fibroids, history of miscarriage, and duration of breastfeeding (r= 0.593, 0.452, 0.446, 0.419, 0.422, respectively). IGF-1 was negatively correlated with CD 3+, CD 4+, and CD 4+\/CD 8+ (r=-0.720, -0.751, and -0.712, respectively). IGF-1 was positively correlated with CD8+ status, history of uterine fibroids, number of fibroids, history of miscarriage, and duration of breastfeeding (r= 0.631, 0.503, 0.444, 0.501, 0.451). The number of fibroids, a history of miscarriage, and the length of breastfeeding were risk variables that impacted the prognosis of patients with uterine fibroids. Conclusions: The levels of IGFBP-3, IGF-1 and CD-8+ in patients with uterine fibroids are relatively high. Moreover, IGFBP-3 and IGF-1 are related to immune factors and patient prognosis.<\/jats:p>","DOI":"10.5937\/jomb0-60550","type":"journal-article","created":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T08:53:06Z","timestamp":1761641586000},"page":"740-748","source":"Crossref","is-referenced-by-count":0,"title":["Risk prognosis correlation of insulin-like growth factor binding protein-3 and insulin-like growth factor-1 in uterine fibroids"],"prefix":"10.5937","volume":"45","author":[{"given":"Tingting","family":"Lin","sequence":"first","affiliation":[{"name":"The People's Hospital of Pingyang, Department of Gynaecology, Wenzhou City, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keke","family":"Qian","sequence":"additional","affiliation":[{"name":"The People's Hospital of Pingyang, Department of Gynaecology, Wenzhou City, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanping","family":"Chen","sequence":"additional","affiliation":[{"name":"The People's Hospital of Pingyang, Department of Gynaecology, Wenzhou City, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengshu","family":"Li","sequence":"additional","affiliation":[{"name":"The People's Hospital of Pingyang, Department of Gynaecology, Wenzhou City, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhang","family":"Zhang","sequence":"additional","affiliation":[{"name":"The People's Hospital of Pingyang, Department of Gynaecology, Wenzhou City, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3964","reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Yuan H, Li N, Wu L, Yao H. Prognosis and treatment of uterine sarcoma found incidentally after myomectomy. Eur J Surg Oncol 2024 Nov; 50(11): 108652. doi: 10.1016\/j.ejso.2024.108652. Epub 2024 Sep 3. PMID: 39241509;","DOI":"10.1016\/j.ejso.2024.108652"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Zanolli NC, Bishop KC, Kuller JA, Price TM, Harris BS. Fibroids and Fertility: A Comparison of Myomectomy and Uterine Artery Embolization on Fertility and Reproductive Outcomes. Obstet Gynecol Surv 2022 Aug; 77(8): 485-94. doi: 10.1097\/OGX.0000000000001052. PMID: 35932289;","DOI":"10.1097\/OGX.0000000000001052"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Sirkeci F Moss J, Belli AM, McPherson K, Daniels J, Manyonda I, Middleton L, Cheed V, Wu O, Lumsden MA; FEMME Trial Collaborative Group. Effects on heavy menstrual bleeding and pregnancy of uterine artery embolisation (UAE) or myomectomy for women with uterine fibroids wishing to avoid hysterectomy: The FEMME randomised controlled trial. Int J Gynecol Obstet 2023 Feb; 160(2): 492-501. doi: 10.1002\/ijgo.14626. PMID: 36511801; PMCID: PMC10107788;","DOI":"10.1002\/ijgo.14626"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Peng J, Wang J, Shu Q, Luo Y, Wang S, Liu Z. Systematic review and meta-analysis of current evidence in uterine artery embolisation vs myomectomy for symptomatic uterine fibroids. Sci Rep 2024 Aug 20; 14(1): 19252. doi: 10.1038\/s41598-024-69754-0. PMID: 39164326; PMCID: PMC11336172;","DOI":"10.1038\/s41598-024-69754-0"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Bao YM, Ma WW, Li S, Jiang L, Yang MJ, Chen JY. The safety and efficacy of myomectomy in the treatment of recurrent uterine fibroids after HIFU. Int J Gynecol Obstet 2024 Dec; 167(3): 997-1003. doi: 10.1002\/ijgo.15757. Epub 2024 Jun 27. PMID: 38935313;","DOI":"10.1002\/ijgo.15757"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Wu L, Li H, Liu Y, Fan Z, Xu J, Li N, Qian X, Lin Z, Li X, Yan J. Research progress of 3D-bioprinted functional pancreas and in vitro tumor models. International Journal of Bioprinting 2024, 10(1), 1256. doi: 10.36922\/ijb.1256;","DOI":"10.36922\/ijb.1256"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Anchan RM, Spies JB, Zhang S, Wojdyla D, Bortoletto P, Terry K, Disler E, Milne A, Gargiulo A, Petrozza J, Brook O, Srouji S, Morton CC, Greenberg J, Wegienka G, Stewart EA, Nicholson WK, Thomas L, Venable S, Laughlin-Tommaso S, Diamond MP, Maxwell GL, Marsh EE, Myers ER, Vines AI, Wise LA, Wallace K, Jacoby VL. Long-term health-related quality of life and symptom severity following hysterectomy, myomectomy, or uterine artery embolisation for the treatment of symptomatic uterine fibroids. Am J Obstet Gynecol 2023 Sep; 229(3): 275.e1-275.e17. doi: 10.1016\/j.ajog.2023.05.020. Epub 2023 May 26. PMID: 37244458;","DOI":"10.1016\/j.ajog.2023.05.020"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Tsiampa E, Tsiampas K, Kapogiannis F. Perioperative and reproductive outcomes' comparison of mini-laparotomy and laparoscopic myomectomy in the management of uterine leiomyomas: a systematic review. Arch Gynecol Obstet 2024 Mar; 309(3): 821-9. doi: 10.1007\/s00404-023-07168-5. Epub 2023 Aug 11. PMID: 37566224;","DOI":"10.1007\/s00404-023-07168-5"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Wu L, Li X, Qian X, Wang S, Liu J, Yan J. Lipid Nanoparticle (LNP) Delivery Carrier-Assisted Targeted Controlled Release mRNA Vaccines in Tumor Immunity. Vaccines (Basel) 2024 Feb 12; 12(2): 186. doi: 10.3390\/vaccines12020186. PMID: 38400169; PMCID: PMC10891594;","DOI":"10.3390\/vaccines12020186"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Chen Y, Yi J, Lin S, Xie X, Liu X, Guo SW. Reproductive outcomes of high-intensity focused ultrasound ablation and myomectomy for uterine fibroids: a systematic review and meta-analysis. Reprod Biomed Online 2025 Jan; 50(1): 104436. doi: 10.1016\/j.rbmo.2024.104436. Epub 2024 Sep 3. PMID: 39616958;","DOI":"10.1016\/j.rbmo.2024.104436"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Wu L, Zheng Y, Liu J, Luo R, Wu D, Xu P, Wu D, Li X. Comprehensive evaluation of the efficacy and safety of LPV\/r drugs in the treatment of SARS and MERS to provide potential treatment options for COVID-19. Aging (Albany NY) 2021 Apr 20; 13(8): 10833-52. doi: 10.18632\/aging.202860. Epub 2021 Apr 20. PMID: 33879634; PMCID: PMC8109137;","DOI":"10.18632\/aging.202860"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Tanigawa T, Omatsu K, Aoki Y, Fusegi A, Omi M, Netsu 5, Okamoto S, Yunokawa M, Nomura H, Kanao H. Impact on prognosis of unexpected uterine sarcoma with scalpel morcellation or enucleation. Gynecol Oncol Rep 2022 Sep 15; 43: 101070. doi: 10.1016\/j.gore.2022.101070. PMID: 36164469; PMCID: PMC9508150;","DOI":"10.1016\/j.gore.2022.101070"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Fajardo OM, Grebenyuk E, Chaves KF, Zhao Z, Ding T, Curlin HL, Harvey LFB. Impact of trainees involvement on surgical outcomes of abdominal and laparoscopic myomectomy. J Obstet Gynecol 2024 Dec; 44(1): 2330697. doi: 10.1080\/01443615.2024.2330697. Epub 2024 Mar 23. PMID: 38520272;","DOI":"10.1080\/01443615.2024.2330697"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Yang ZM, Malka R, Erwin DZ, Postma G. Airway and Voice Outcomes After Thyroarytenoid Myomectomy for Bilateral Vocal Fold Immobility. Laryngoscope 2024 Oct; 134(10): 4307-12. doi: 10.1002\/lary.31545. Epub 2024 May 28. PMID: 38807469;","DOI":"10.1002\/lary.31545"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Mahalingam M, Hu M, Schointuch M, Szychowski JM, Harper L, Owen J, Sinkey R. Uterine myomas: effect of prior myomectomy on pregnancy outcomes. J Matern Fetal Neonatal Med 2022 Dec; 35(25): 8492-7. doi: 10.1080\/14767058.2021.1984424. Epub 2021 Oct 6. PMID: 34615420; PMCID: PMC10961099;","DOI":"10.1080\/14767058.2021.1984424"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Thao V, Moriarty JP, Stewart EA, Borah BJ. Cost-effectiveness of Myomectomy versus Hysterectomy in Women with Uterine Fibroids. J Minim Invasive Gynecol 2023 Oct; 30(10): 813-9. doi: 10.1016\/j.jmig.2023.06.001. Epub 2023 Jun 5. PMID: 37286130;","DOI":"10.1016\/j.jmig.2023.06.001"},{"key":"ref17","unstructured":"Yu WN, Pan SY, Wang C, Huang ZD, Wang XL, Zhu S, Ding Y, Wang XL. Clinicopathological features and prognosis of 117 cases of fumarate hydratase-deficient uterine leiomyomas. Zhonghua Fu Chan Ke Za Zhi 2025 Jun 25; 60(6): 450-60. Chinese. doi: 10.3760\/cma.j.cn112141-20250205-00040. PMID: 40582968;"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Wu L, Zhong Y, Wu D, Xu P, Ruan X, Yan J, Liu J, Li X. Immunomodulatory Factor TIM3 of Cytolytic Active Genes Affected the Survival and Prognosis of Lung Adenocarcinoma Patients by Multi-Omics Analysis. Biomedicines 2022 Sep 10; 10(9): 2248. doi: 10.3390\/biomedicines10092248. PMID: 36140350; PMCID: PMC9496572;","DOI":"10.3390\/biomedicines10092248"},{"key":"#cr-split#-ref19.1","doi-asserted-by":"crossref","unstructured":"Allen A, Schembri M, Parvataneni R, Waetjen LE, Varon S, Salamat-Saberi N, Tassone S, Williams N, Kho KA, Jacoby VL. Pregnancy Outcomes After Laparoscopic Radiofrequency Ablation of Uterine Leiomyomas Compared With Myomectomy. Obstet Gynecol 2024 May 1","DOI":"10.1097\/AOG.0000000000005548"},{"key":"#cr-split#-ref19.2","doi-asserted-by":"crossref","unstructured":"143(5): 612-8. doi: 10.1097\/AOG.0000000000000554. Epub 2024 Mar 1. PMID: 38422502;","DOI":"10.1097\/AOG.0000000000000554"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Wu L, Chen X, Zeng Q, Lai Z, Fan Z, Ruan X, Li X, Yan J. NR5A2 gene affects the overall survival of LUAD patients by regulating the activity of CSCs through SNP pathway by OCLR algorithm and immune score. Heliyon 2024 Mar 28; 10(7): e28282. doi: 10.1016\/j.heliyon.2024.e28282. PMID: 38601554; PMCID: PMC11004709;","DOI":"10.1016\/j.heliyon.2024.e28282"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Isono W, Maruyama M. A new uterine endometrium preservation hysteroscopic myomectomy: Introduction of improved procedures and a retrospective analysis of 94 cases. Eur J Obstet Gynecol Reprod Biol X 2024 Nov 14; 24: 100354. doi: 10.1016\/j.eurox.2024.100354. PMID: 39639964; PMCID: PMC11617695;","DOI":"10.1016\/j.eurox.2024.100354"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Kitade M, Kumakiri J, Kobori H, Murakami K. The effectiveness of relugolix compared with leuprorelin for preoperative therapy before laparoscopic myomectomy in premenopausal women, diagnosed with uterine fibroids: protocol for a randomised controlled study (MyLacR study). Trials 2024 May 24; 25(1): 343. doi: 10.1186\/s13063-024-08170-1. PMID: 38790029; PMCID: PMC11127340;","DOI":"10.1186\/s13063-024-08170-1"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Wu L, Liu Q, Ruan X, Luan X, Zhong Y, Liu J, Yan J, Li X. Multiple Omics Analysis of the Role of RBM10 Gene Instability in Immune Regulation and Drug Sensitivity in Patients with Lung Adenocarcinoma (LUAD). Biomedicines 2023 Jun 29; 11(7): 1861. doi: 10.3390\/biomedicines11071861. PMID: 37509501; PMCID: PMC10377220;","DOI":"10.3390\/biomedicines11071861"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Wang P, Di Francesco L, Seeraj V, Kumari S, Moustafa S, Uzianbaeva L, Mehdizadeh A. Minimally Invasive Myomectomy with Temporary Bilateral Uterine Artery Blockage at Anterior Cul-de-Sac. JSLS 2025 Jan-Mar; 29(1): e2024.00078. doi: 10.4293\/JSLS.2024.00078. Epub 2025 Mar 25. PMID: 40144384; PMCID: PMC11935644;","DOI":"10.4293\/JSLS.2024.00078"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Wu L, Zheng Y, Ruan X, Wu D, Xu P, Liu J, Wu D, Li X. Long-chain noncoding ribonucleic acids affect the survival and prognosis of patients with esophageal adenocarcinoma through the autophagy pathway: construction of a prognostic model. Anticancer Drugs 2022 Jan 1; 33(1): e590-e603. doi: 10.1097\/CAD.0000000000001189. PMID: 34338240; PMCID: PMC8670349;","DOI":"10.1097\/CAD.0000000000001189"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Sinha R, Bana R, Peddappolla SC. Feasibility and surgical outcomes of robotic myomectomy for large and multiple uterine fibroidsinsights from a decade of experience at a single center. J Robot Surg 2025 Jul 11; 19(1): 377. doi: 10.1007\/s11701-025-02538-4. PMID: 40646378; PMCID: PMC12254167;","DOI":"10.1007\/s11701-025-02538-4"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Wu L, Zhong Y, Yu X, Wu D, Xu P, Lv L, Ruan X, Liu Q, Feng Y, Liu J, Li X. Selective poly adenylation predicts the efficacy of immunotherapy in patients with lung adenocarcinoma by multiple omics research. Anticancer Drugs 2022 Oct 1; 33(9): 943-59. doi: 10.1097\/CAD.0000000000001319. Epub 2022 Aug 9. PMID: 35946526; PMCID: PMC9481295;","DOI":"10.1097\/CAD.0000000000001319"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Sandrieser L, Kuessel L, Perricos A, Wenzl R, Husslein H. Myomectomy for a large uterine fibroid via mini-laparotomy: a step-by-step video tutorial. Fertil Steril 2022 Feb; 117(2): 456-7. doi: 10.1016\/j.fertnstert.2021.11.018. Epub 2021 Dec 31. PMID: 34980426;","DOI":"10.1016\/j.fertnstert.2021.11.018"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Wu L, Yang L, Qian X, Hu W, Wang S, Yan J. Mannan-Decorated Lipid Calcium Phosphate Nanoparticle Vaccine Increased the Antitumor Immune Response by Modulating the Tumor Microenvironment. J Funct Biomater 2024 Aug 16; 15(8): 229. doi: 10.3390\/jfb15080229. PMID: 39194667; PMCID: PMC11355305;","DOI":"10.3390\/jfb15080229"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Anchan RM, Wojdyla D, Bortoletto P, Terry K, Disler E, Milne A, Gargiulo A, Petrozza J, Brook O, Srouji S, Morton CC, Greenberg J, Wegienka G, Stewart EA, Nicholson WK, Thomas L, Venable S, Laughlin-Tommaso S, Diamond MP, Maxwell GL, Marsh EE, Myers ER, Vines AI, Wise LA, Wallace K, Jacoby VL, Spies JB. A Comparative Analysis of Health-Related Quality of Life 1 Year Following Myomectomy or Uterine Artery Embolization: Findings from the COMPARE-UF Registry. J Womens Health (Larchmt) 2023 Apr; 32(4): 423-33. doi: 10.1089\/jwh.2022.0133. Epub 2023 Jan 13. PMID: 36637808; PMCID: PMC10079244;","DOI":"10.1089\/jwh.2022.0133"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Zhou Y, Lin Y, Xu D, He L, Huang L. A comparative study of prone split-leg position and lithotomy position in posterior uterine myomectomy by transvaginal natural orifice transluminal endoscopic surgery. BMC Womens Health 2025 Apr 12; 25(1): 177. doi: 10.1186\/s12905-025-03709-z. PMID: 40221707; PMCID: PMC11994009;","DOI":"10.1186\/s12905-025-03709-z"}],"container-title":["Journal of Medical Biochemistry"],"original-title":["Korelacija izme\u0111u faktora prognoze rizika kod insulinu sli\u010dnog faktora rasta-1 (IGF-1) i proteina koji vezuje insulinu sli\u010dan faktor rasta-3 (IGFBP-3) kod mioma materice"],"language":"en","link":[{"URL":"https:\/\/aseestant.ceon.rs\/index.php\/jomb\/article\/download\/60550\/29185","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/scindeks-clanci.ceon.rs\/data\/pdf\/1452-8258\/2026\/1452-82582604740L.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T14:19:56Z","timestamp":1776262796000},"score":1,"resource":{"primary":{"URL":"https:\/\/scindeks.ceon.rs\/Article.aspx?artid=1452-82582604740L"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.5937\/jomb0-60550","relation":{},"ISSN":["1452-8258","1452-8266"],"issn-type":[{"value":"1452-8258","type":"print"},{"value":"1452-8266","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]}}}